{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:04:38Z","timestamp":1789574678934,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Health Department of the Government of Navarra","award":["61\/2015"],"award-info":[{"award-number":["61\/2015"]}]},{"DOI":"10.13039\/501100012514","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red-Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n","doi-asserted-by":"publisher","award":["CB12\/03\/3002"],"award-info":[{"award-number":["CB12\/03\/3002"]}],"id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201630.10"],"award-info":[{"award-number":["201630.10"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00394-020-02476-x","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T14:16:13Z","timestamp":1611152173000},"page":"3043-3057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0479-8825","authenticated-orcid":false,"given":"Nuria","family":"Perez-Diaz-del-Campo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-8197","authenticated-orcid":false,"given":"Bertha Araceli","family":"Marin-Alejandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3468-8045","authenticated-orcid":false,"given":"Irene","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Ignacio","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Elorz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-3073","authenticated-orcid":false,"given":"Jos\u00e9 Ignacio","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1527-0092","authenticated-orcid":false,"given":"Alberto","family":"Benito-Boillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1885-8457","authenticated-orcid":false,"given":"Jose I.","family":"Riezu-Boj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3228-9916","authenticated-orcid":false,"given":"Ferm\u00edn I.","family":"Milagro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6940-0761","authenticated-orcid":false,"given":"Josep A.","family":"Tur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-6941","authenticated-orcid":false,"given":"J. Alfredo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6475-5387","authenticated-orcid":false,"given":"Itziar","family":"Abete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3926-0892","authenticated-orcid":false,"given":"M. Angeles","family":"Zulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"2476_CR1","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","volume":"24","author":"S Leoni","year":"2018","unstructured":"Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L (2018) Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 24:3361\u20133373. https:\/\/doi.org\/10.3748\/wjg.v24.i30.3361","journal-title":"World J Gastroenterol."},{"key":"2476_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM (2019) Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 70:531\u2013544. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033","journal-title":"J Hepatol."},{"key":"2476_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 64:1388\u20131402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004","journal-title":"J Hepatol."},{"key":"2476_CR4","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3390\/nu11102359","volume":"11","author":"G Recaredo","year":"2019","unstructured":"Recaredo G, Marin-Alejandre BA, Cantero I, Monreal JI, Herrero JI, Benito-Boillos A, Elorz M, Tur JA, Mart\u00ednez JA, Zulet MA et al (2019) Association between different animal protein sources and liver status in obese subjects with non-alcoholic fatty liver disease: Fatty Liver in Obesity (FLiO) Study. Nutrients. 11:2359. https:\/\/doi.org\/10.3390\/nu11102359","journal-title":"Nutrients."},{"key":"2476_CR5","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.3390\/ijerph16152755","volume":"16","author":"AE Taliento","year":"2019","unstructured":"Taliento AE, Dallio M, Federico A, Prati D, Valenti L (2019) Novel insights into the genetic landscape of nonalcoholic fatty liver disease. IJERPH 16:2755. https:\/\/doi.org\/10.3390\/ijerph16152755","journal-title":"IJERPH"},{"key":"2476_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/nu11020322","volume":"11","author":"BA Marin-Alejandre","year":"2019","unstructured":"Marin-Alejandre BA, Abete I, Cantero I, Riezu-Boj JI, Milagro FI, Monreal JI, Elorz M, Herrero JI, Benito-Boillos A, Quiroga J et al (2019) Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: a comparison with healthy controls. Nutrients. 11:322. https:\/\/doi.org\/10.3390\/nu11020322","journal-title":"Nutrients."},{"key":"2476_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/postgradmedj-2018-136316","volume":"95","author":"E Jennison","year":"2019","unstructured":"Jennison E, Patel J, Scorletti E, Byrne CD (2019) Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med 95:314\u2013322. https:\/\/doi.org\/10.1136\/postgradmedj-2018-136316","journal-title":"Postgrad Med"},{"key":"2476_CR8","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","volume":"25","author":"J Zhou","year":"2019","unstructured":"Zhou J, Cai J, She Z, Li H (2019) Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice. World J Gastroenterol 25:1307\u20131326. https:\/\/doi.org\/10.3748\/wjg.v25.i11.1307","journal-title":"World J Gastroenterol"},{"key":"2476_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.7150\/ijbs.30121","volume":"15","author":"R Ullah","year":"2019","unstructured":"Ullah R, Rauf N, Nabi G, Ullah H, Shen Y, Zhou YD, Fu J (2019) Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease: recent updates. Int J Biol Sci 15:265\u2013276. https:\/\/doi.org\/10.7150\/ijbs.30121","journal-title":"Int J Biol Sci"},{"key":"2476_CR10","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.3390\/ijerph16193570","volume":"16","author":"V Kup\u010dov\u00e1","year":"2019","unstructured":"Kup\u010dov\u00e1 V, Fedele\u0161ov\u00e1 M, Bulas J, Kozmonov\u00e1 P, Tureck\u00fd L (2019) Overview of the pathogenesis, genetic, and non-invasive clinical, biochemical, and scoring methods in the assessment of NAFLD. Int J Environ Res Public Health. 16:3570. https:\/\/doi.org\/10.3390\/ijerph16193570","journal-title":"Int J Environ Res Public Health."},{"key":"2476_CR11","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, Wai-Sun Wong V, Yilmaz Y, George J, Fan J et al (2019) Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69:2672\u20132682. https:\/\/doi.org\/10.1002\/hep.30251","journal-title":"Hepatology"},{"key":"2476_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/nu12051260","volume":"12","author":"N Perez-Diaz-del-Campo","year":"2020","unstructured":"Perez-Diaz-del-Campo N, Abete I, Cantero I, Marin-Alejandre BA, Monreal JI, Elorz M, Herrero JI, Benito-Boillos A, Riezu-Boj JI, Milagro FI et al (2020) Association of the\u00a0SH2B1\u00a0rs7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease. Nutrients 12:1260. https:\/\/doi.org\/10.3390\/nu12051260","journal-title":"Nutrients"},{"key":"2476_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1055\/s-0039-1679920","volume":"39","author":"S Sookoian","year":"2019","unstructured":"Sookoian S, Pirola CJ (2019) Genetics of nonalcoholic fatty liver disease: from pathogenesis to therapeutics. Semin Liver Dis 39:124\u2013140. https:\/\/doi.org\/10.1055\/s-0039-1679920","journal-title":"Semin Liver Dis"},{"key":"2476_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4239\/wjd.v5.i4.511","volume":"5","author":"L Rui","year":"2014","unstructured":"Rui L (2014) SH2B1 regulation of energy balance, body weight, and glucose metabolism. World J Diabetes. 5:511\u2013526. https:\/\/doi.org\/10.4239\/wjd.v5.i4.511","journal-title":"World J Diabetes."},{"key":"2476_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1172\/JCI29417","volume":"117","author":"D Ren","year":"2007","unstructured":"Ren D, Zhou Y, Morris D, Li M, Li Z, Rui L (2007) Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Investig 117:397\u2013406. https:\/\/doi.org\/10.1172\/JCI29417","journal-title":"J Clin Investig"},{"key":"2476_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0083269","volume":"8","author":"L Sheng","year":"2013","unstructured":"Sheng L, Liu Y, Jiang L, Chen Z, Zhou Y, Cho KW, Rui L (2013) Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice. PLoS ONE 8:1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0083269","journal-title":"PLoS ONE"},{"key":"2476_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000368425","volume":"66","author":"ML Mansego","year":"2015","unstructured":"Mansego ML, Milagro FI, Zulet MA, Martinez JA (2015) SH2B1 CpG-SNP is associated with body weight reduction in obese subjects following a dietary restriction program. Ann Nutr Metab 66:1\u20139. https:\/\/doi.org\/10.1159\/000368425","journal-title":"Ann Nutr Metab"},{"key":"2476_CR18","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.2337\/db19-0608","volume":"68","author":"A Flores","year":"2019","unstructured":"Flores A, Argetsinger LS, Stadler LKJ, Malaga AE, Vander PB, Desantis LC, Joe RM, Cline JM, Keogh JM, Henning E et al (2019) Crucial role of the SH2B1 PH domain for the control of energy balance. Diabetes 68:2049\u20132062. https:\/\/doi.org\/10.2337\/db19-0608","journal-title":"Diabetes"},{"key":"2476_CR19","doi-asserted-by":"publisher","first-page":"109651","DOI":"10.1016\/j.biopha.2019.109651","volume":"121","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Duan C, Zhang C (2020) Biomedicine and pharmacotherapy new perspective on SH2B1: an accelerator of cancer progression. Biomed Pharmacother. 121:109651. https:\/\/doi.org\/10.1016\/j.biopha.2019.109651","journal-title":"Biomed Pharmacother."},{"key":"2476_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/ahg.12165","volume":"80","author":"LA Lange","year":"2016","unstructured":"Lange LA, Graff M, Lange EM, Young KL, Richardson AS, Mohlke KL, North KE, Harris KM, Gordon-Larsen P (2016) Evidence for association between SH2B1 gene variants and glycated hemoglobin in nondiabetic european american young adults: the add health study. Ann Hum Genet. 80:294\u2013305. https:\/\/doi.org\/10.1111\/ahg.12165","journal-title":"Ann Hum Genet."},{"key":"2476_CR21","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.3390\/ijms21082986","volume":"21","author":"M Meroni","year":"2020","unstructured":"Meroni M, Longo M, Rustichelli A, Dongiovanni P (2020) Nutrition and genetics in NAFLD: the perfect binomium. Int J Mol Sci. 21:2986. https:\/\/doi.org\/10.3390\/ijms21082986","journal-title":"Int J Mol Sci."},{"key":"2476_CR22","doi-asserted-by":"publisher","first-page":"110620","DOI":"10.1016\/j.nut.2019.110620","volume":"71","author":"V Bull\u00f3n-Vela","year":"2020","unstructured":"Bull\u00f3n-Vela V, Abete I, Tur JA, Pint\u00f3 X, Corbella E, Mart\u00ednez-Gonz\u00e1lez MA, Toledo E, Corella D, Mac\u00edas M, Tinahones F et al (2020) Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features. Nutrition. 71:110620. https:\/\/doi.org\/10.1016\/j.nut.2019.110620","journal-title":"Nutrition."},{"key":"2476_CR23","doi-asserted-by":"publisher","first-page":"E3662","DOI":"10.3390\/ijms19113662","volume":"19","author":"C Galarregui","year":"2018","unstructured":"Galarregui C, Zulet MA, Cantero I, Mar\u00edn-Alejandre BA, Monreal JI, Elorz M, Benito-Boillos A, Herrero JI, Tur JA, Abete I et al (2018) Interplay of glycemic index, glycemic load, and dietary antioxidant capacity with insulin resistance in subjects with a cardiometabolic risk profile. Int J Mol Sci 19:E3662. https:\/\/doi.org\/10.3390\/ijms19113662","journal-title":"Int J Mol Sci"},{"key":"2476_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/nu9070667","volume":"9","author":"I Cantero","year":"2017","unstructured":"Cantero I, Abete I, Monreal JI, Martinez JA, Zulet MA (2017) Fruit fiber consumption specifically improves liver health status in obese subjects under energy restriction. Nutrients. 9:667. https:\/\/doi.org\/10.3390\/nu9070667","journal-title":"Nutrients."},{"key":"2476_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jhep.2019.04.019","volume":"71","author":"ME Rinella","year":"2019","unstructured":"Rinella ME, Tacke F, Sanyal AJ, Anstee QM (2019) Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD. J Hepatol. 71:823\u2013833. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.019","journal-title":"J Hepatol."},{"key":"2476_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/medicines6010041","volume":"6","author":"U Iqbal","year":"2019","unstructured":"Iqbal U, Perumpail BJ, Akhtar D, Kim D, Ahmed A (2019) The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease. Medicines (Basel) 6:41. https:\/\/doi.org\/10.3390\/medicines6010041","journal-title":"Medicines (Basel)"},{"key":"2476_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3389\/fgene.2019.00686","volume":"10","author":"O Ramos-Lopez","year":"2019","unstructured":"Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Cuervo M, Goni L, Martinez JA (2019) Models integrating genetic and lifestyle interactions on two adiposity phenotypes for personalized prescription of energy-restricted diets with different macronutrient distribution. Front. Genet. 10:686. https:\/\/doi.org\/10.3389\/fgene.2019.00686","journal-title":"Front. Genet."},{"key":"2476_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.diabres.2018.01.003","volume":"137","author":"DA de Luis","year":"2018","unstructured":"de Luis DA, Izaola O, Primo D, Aller R, Ortola A, G\u00f3mez E, Lopez JJ (2018) The association of SNP276G>T at adiponectin gene with insulin resistance and circulating adiponectin in response to two different hypocaloric diets. Diabetes Res Clin Pract 137:93\u201399. https:\/\/doi.org\/10.1016\/j.diabres.2018.01.003","journal-title":"Diabetes Res Clin Pract"},{"key":"2476_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrendo.2014.175","volume":"10","author":"JA Martinez","year":"2014","unstructured":"Martinez JA, Navas-Carretero S, Saris WH, Astrup A (2014) Personalized weight loss strategies\u2014the role of macronutrient distribution. Nat. Rev. Endocrinol. 10:749\u2013760. https:\/\/doi.org\/10.1038\/nrendo.2014.175","journal-title":"Nat. Rev. Endocrinol."},{"key":"2476_CR30","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00394-017-1499-7","volume":"57","author":"AC Kaliora","year":"2018","unstructured":"Kaliora AC, Kalafati IP, Gioxari A, Diolintzi A, Kokkinos A, Dedoussis GV (2018) A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326. Eur J Nutr. 57:2227\u20132235. https:\/\/doi.org\/10.1007\/s00394-017-1499-7","journal-title":"Eur J Nutr."},{"key":"2476_CR31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/ijms18071534","volume":"18","author":"P Dongiovanni","year":"2017","unstructured":"Dongiovanni P, Valenti L (2017) A nutrigenomic approach to non-alcoholic fatty liver disease. Int J Mol Sci. 18:1534. https:\/\/doi.org\/10.3390\/ijms18071534","journal-title":"Int J Mol Sci."},{"key":"2476_CR32","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/nu11102543","volume":"11","author":"BA Marin-Alejandre","year":"2019","unstructured":"Marin-Alejandre BA, Abete I, Cantero I, Monreal JI, Elorz M, Herrero JI, Benito-Boillos A, Quiroga J, Martinez-Echeverria A, Uriz-Otano JI et al (2019) The metabolic and hepatic impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: the fatty liver in obesity (FLiO) randomized controlled trial. Nutrients. 11:2543. https:\/\/doi.org\/10.3390\/nu11102543","journal-title":"Nutrients."},{"key":"2476_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24376","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, Ratziu V, McCullough A (2011) Endpoints and clinical trial design for nonalcoholi steatohepatitis. Hepatology. https:\/\/doi.org\/10.1002\/hep.24376","journal-title":"Hepatology"},{"key":"2476_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"2476_CR35","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1017\/S0007114509993837","volume":"103","author":"JD Fern\u00e1ndez-Ballart","year":"2010","unstructured":"Fern\u00e1ndez-Ballart JD, Pi\u00f1ol JL, Zazpe I, Corella D, Carrasco P, Toledo E, Perez-Bauer M, Mart\u00ednez-Gonz\u00e1lez MA, Salas-Salvad\u00f3 J, Mart\u00edn-Moreno JM (2010) Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr. 103:1808\u20131816. https:\/\/doi.org\/10.1017\/S0007114509993837","journal-title":"Br J Nutr."},{"key":"2476_CR36","doi-asserted-by":"publisher","first-page":"e0210726","DOI":"10.1371\/journal.pone.0210726","volume":"14","author":"AM Galmes-Panades","year":"2019","unstructured":"Galmes-Panades AM, Konieczna J, Abete I, Colom A, Rosique-Esteban N, Zulet MA, V\u00e1zquez Z, Estruch R, Vidal J, Toledo E et al (2019) Lifestyle factors and visceral adipose tissue: results from the PREDIMED-PLUS study. PLoS ONE 14:e0210726. https:\/\/doi.org\/10.1371\/journal.pone.0210726","journal-title":"PLoS ONE"},{"key":"2476_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2165\/00007256-200232120-00004","volume":"32","author":"C Tudor-Locke","year":"2002","unstructured":"Tudor-Locke C, Williams JE, Reis JP, Pluto D (2002) Utility of pedometers for assessing physical activity: convergent validity. Sport Med. 32:795\u2013808. https:\/\/doi.org\/10.2165\/00007256-200232120-00004","journal-title":"Sport Med."},{"key":"2476_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12944-018-0932-0","volume":"17","author":"Q Wang","year":"2018","unstructured":"Wang Q, Zheng D, Liu J, Fang L, Li Q (2018) Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study. Lipids Health Dis. 17:284. https:\/\/doi.org\/10.1186\/s12944-018-0932-0","journal-title":"Lipids Health Dis."},{"key":"2476_CR39","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1017\/S0007114513002778","volume":"111","author":"R de la Iglesia","year":"2014","unstructured":"de la Iglesia R, Lopez-Legarrea P, Abete I, Bondia-Pons I, Navas-Carretero S, Forga L, Martinez JA, Zulet MA (2014) A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project. Br J Nutr. 111:643\u2013652. https:\/\/doi.org\/10.1017\/S0007114513002778","journal-title":"Br J Nutr."},{"key":"2476_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6:33. https:\/\/doi.org\/10.1186\/1471-230X-6-33","journal-title":"BMC Gastroenterol."},{"key":"2476_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.7150\/ijms.28044","volume":"16","author":"I Cantero","year":"2019","unstructured":"Cantero I, Elorz M, Abete I, Marin BA, Herrero JI, Monreal JI, Benito A, Quiroga J, Mart\u00ednez A, Huarte MP et al (2019) Ultrasound\/Elastography techniques, lipidomic and blood markers compared to magnetic resonance imaging in non-alcoholic fatty liver disease adults. Int J Med Sci. 16:75\u201383. https:\/\/doi.org\/10.7150\/ijms.28044","journal-title":"Int J Med Sci."},{"key":"2476_CR42","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/dom.13285","volume":"20","author":"F Bril","year":"2018","unstructured":"Bril F, Mill\u00e1n L, Kalavalapalli S, McPhaul MJ, Caulfield MP, Martinez-Arranz I, Alonso C, Ortiz Betes P, Mato JM, Cusi K (2018) Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 20:1702\u20131709. https:\/\/doi.org\/10.1111\/dom.13285","journal-title":"Diabetes Obes Metab."},{"key":"2476_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nut.2017.10.008","volume":"47","author":"O Ramos-Lopez","year":"2018","unstructured":"Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Goni L, Cuervo M, Martinez JA (2018) Association of the Gly482Ser PPARGC1A gene variant with different cholesterol outcomes in response to two energy-restricted diets in subjects with excessive weight. Nutrition. 47:83\u201389. https:\/\/doi.org\/10.1016\/j.nut.2017.10.008","journal-title":"Nutrition."},{"key":"2476_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.numecd.2017.11.006","volume":"28","author":"O Ramos-Lopez","year":"2018","unstructured":"Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Goni L, Cuervo M, Martinez JA (2018) Differential lipid metabolism outcomes associated with ADRB2 gene polymorphisms in response to two dietary interventions in overweight\/obese subjects. Nutr Metab Cardiovasc Dis. 28:165\u2013172. https:\/\/doi.org\/10.1016\/j.numecd.2017.11.006","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"2476_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0038-1677517","volume":"39","author":"R Younes","year":"2019","unstructured":"Younes R, Bugianesi E (2019) NASH in lean individuals. Semin Liver Dis. 39:86\u201395. https:\/\/doi.org\/10.1055\/s-0038-1677517","journal-title":"Semin Liver Dis."},{"issue":"4","key":"2476_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","volume":"7","author":"N Stefan","year":"2019","unstructured":"Stefan N, H\u00e4ring HU, Cusi K (2019) Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 7(4):313\u2013324. https:\/\/doi.org\/10.1016\/S2213-8587(18)30154-2","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2476_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000477729","volume":"10","author":"O Ramos-Lopez","year":"2017","unstructured":"Ramos-Lopez O, Milagro FI, Allayee H, Chmurzynska A, Choi MS, Curi R, De Caterina R, Ferguson LR, Goni L, Kang JX et al (2017) Guide for current nutrigenetic, nutrigenomic, and nutriepigenetic approaches for precision nutrition involving the prevention and management of chronic diseases associated with obesity. J Nutrigenet Nutrigenomics. 10:43\u201362. https:\/\/doi.org\/10.1159\/000477729","journal-title":"J Nutrigenet Nutrigenomics."},{"key":"2476_CR48","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.3390\/ijerph16173104","volume":"16","author":"C Tana","year":"2019","unstructured":"Tana C, Ballestri S, Ricci F, Di Vincenzo A, Ticinesi A, Gallina S, Giamberardino MA, Cipollone F, Sutton R, Vettor R et al (2019) Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications. Int J Environ Res Public Health. 16:3104. https:\/\/doi.org\/10.3390\/ijerph16173104","journal-title":"Int J Environ Res Public Health."},{"key":"2476_CR49","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/oby.2009.413","volume":"18","author":"A Haupt","year":"2010","unstructured":"Haupt A, Thamer C, Heni M, Machicao F, Machann J, Schick F, Stefan N, Fritsche A, H\u00e4ring HU, Staiger H (2010) Novel obesity risk loci do not determine distribution of body fat depots: a whole-body MRI\/MRS study. Obesity (Silver Spring). 18:1212\u20131217. https:\/\/doi.org\/10.1038\/oby.2009.413","journal-title":"Obesity (Silver Spring)."},{"key":"2476_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.12998\/wjcc.v6.i8.167","volume":"6","author":"JZ Wang","year":"2018","unstructured":"Wang JZ, Cao HX, Chen JN, Pan Q (2018) PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease. World J Clin Cases. 6:167\u2013175. https:\/\/doi.org\/10.12998\/wjcc.v6.i8.167","journal-title":"World J Clin Cases."},{"key":"2476_CR51","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/circulationaha.110.956839","volume":"123","author":"DE Handy","year":"2011","unstructured":"Handy DE, Castro R, Loscalzo J (2011) Epigenetic modifications: Basic mechanisms and role in cardiovascular disease. Circulation 123:2145\u20132156. https:\/\/doi.org\/10.1161\/circulationaha.110.956839","journal-title":"Circulation"},{"key":"2476_CR52","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1210\/me.2007-0111","volume":"21","author":"Z Li","year":"2007","unstructured":"Li Z, Zhou Y, Carter-Su C, Myers MG Jr, Rui L (2007) SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and-independent mechanisms. Mol Endocrinol. 21:2270\u20132281. https:\/\/doi.org\/10.1210\/me.2007-0111","journal-title":"Mol Endocrinol."},{"key":"2476_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.15403\/jgld-179","volume":"28","author":"SR Mirhafez","year":"2019","unstructured":"Mirhafez SR, Farimani AR, Dehhabe M, Bidkhori M, Hariri M, Ghouchani BF, Abdollahi F (2019) Effect of phytosomal curcumin on circulating levels of adiponectin and leptin in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial. J Gastrointestin Liver Dis. 28:183\u2013189. https:\/\/doi.org\/10.15403\/jgld-179","journal-title":"J Gastrointestin Liver Dis."},{"key":"2476_CR54","doi-asserted-by":"publisher","first-page":"154028","DOI":"10.1016\/j.metabol.2019.154028","volume":"103","author":"C Boutari","year":"2020","unstructured":"Boutari C, Mantzoros CS (2020) Adiponectin and leptin in the diagnosis and therapy of NAFLD. Metabolism. 103:154028. https:\/\/doi.org\/10.1016\/j.metabol.2019.154028","journal-title":"Metabolism."},{"key":"2476_CR55","doi-asserted-by":"publisher","first-page":"G329","DOI":"10.1152\/ajpgi.00044.2018","volume":"315","author":"S Hohenester","year":"2018","unstructured":"Hohenester S, Christiansen S, Nagel J, Wimmer R, Artmann R, Denk G, Bischoff M, Bischoff G, Rust C (2018) Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis. Am J Physiol Gastrointest Liver Physiol. 315:G329\u2013G338. https:\/\/doi.org\/10.1152\/ajpgi.00044.2018","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"2476_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jnutbio.2018.03.025","volume":"58","author":"S Spahis","year":"2018","unstructured":"Spahis S, Alvarez F, Ahmed N, Dubois J, Jalbout R, Paganelli M, Grzywacz K, Delvin E, Peretti N, Levy E (2018) Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids. J Nutr Biochem. 58:28\u201336. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.03.025","journal-title":"J Nutr Biochem."},{"key":"2476_CR57","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/nu9080800","volume":"9","author":"T Eslamparast","year":"2017","unstructured":"Eslamparast T, Tandon P, Raman M (2017) Dietary composition independent of weight loss in the management of non-alcoholic fatty liver disease. Nutrients. 9:800. https:\/\/doi.org\/10.3390\/nu9080800","journal-title":"Nutrients."},{"key":"2476_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cca.2015.08.012","volume":"450","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Jang HB, Kim HJ, Ahn Y, Hong KW, Cho SB, Kang JH, Park SI (2015) The dietary monounsaturated to saturated fatty acid ratio modulates the genetic effects of GCKR on serum lipid levels in children. Clin Chim Acta. 450:155\u2013161. https:\/\/doi.org\/10.1016\/j.cca.2015.08.012","journal-title":"Clin Chim Acta."},{"key":"2476_CR59","doi-asserted-by":"publisher","first-page":"e37827","DOI":"10.1371\/journal.pone.0037827","volume":"7","author":"N Santoro","year":"2012","unstructured":"Santoro N, Savoye M, Kim G, Marotto K, Shaw MM, Pierpont B, Caprio S (2012) Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6\/omega3 PUFA intake. PLoS ONE 7:e37827. https:\/\/doi.org\/10.1371\/journal.pone.0037827","journal-title":"PLoS ONE"},{"key":"2476_CR60","doi-asserted-by":"publisher","first-page":"18057","DOI":"10.1038\/s41598-017-18386-8","volume":"7","author":"F Hosseini-Esfahani","year":"2017","unstructured":"Hosseini-Esfahani F, Koochakpoor G, Daneshpour MS, Mirmiran P, Sedaghati-Khayat B, Azizi F (2017) The interaction of fat mass and obesity associated gene polymorphisms and dietary fiber intake in relation to obesity phenotypes. Sci Rep. 7:18057. https:\/\/doi.org\/10.1038\/s41598-017-18386-8","journal-title":"Sci Rep."},{"key":"2476_CR61","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/nu10060789","volume":"10","author":"L Goni","year":"2018","unstructured":"Goni L, Riezu-Boj JI, Milagro FI, Corrales FJ, Ortiz L, Cuervo M, Mart\u00ednez JA (2018) Interaction between an ADCY3 genetic variant and two weight-lowering diets affecting body fatness and body composition outcomes depending on macronutrient distribution: a randomized trial. Nutrients. 10:789. https:\/\/doi.org\/10.3390\/nu10060789","journal-title":"Nutrients."},{"key":"2476_CR62","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/ijo.2017.169","volume":"41","author":"CA Celis-Morales","year":"2017","unstructured":"Celis-Morales CA, Lyall DM, Gray SR, Steell L, Anderson J, Iliodromiti S, Welsh P, Guo Y, Petermann F, Mackay DF et al (2017) Dietary fat and total energy intake modifies the association of genetic profile risk score on obesity: evidence from 48 170 UK Biobank participants. Int J Obes. 41:1761\u20131768. https:\/\/doi.org\/10.1038\/ijo.2017.169","journal-title":"Int J Obes."},{"key":"2476_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41574-020-0346-8","volume":"16","author":"R San-Cristobal","year":"2020","unstructured":"San-Cristobal R, Navas-Carretero S, Mart\u00ednez-Gonz\u00e1lez M\u00c1, Ordovas JM, Mart\u00ednez JA (2020) Contribution of macronutrients to obesity: implications for precision nutrition. Nat Rev Endocrinol. 16:305\u2013320. https:\/\/doi.org\/10.1038\/s41574-020-0346-8","journal-title":"Nat Rev Endocrinol."},{"key":"2476_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1743-7075-9-65","volume":"9","author":"P Yoganathan","year":"2012","unstructured":"Yoganathan P, Karunakaran S, Ho MM, Clee SM (2012) Nutritional regulation of genome-wide association obesity genes in a tissue-dependent manner. Nutr Metab (Lond). 9:65. https:\/\/doi.org\/10.1186\/1743-7075-9-65","journal-title":"Nutr Metab (Lond)."},{"key":"2476_CR65","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/oby.2011.236","volume":"20","author":"R Gutierrez-Aguilar","year":"2012","unstructured":"Gutierrez-Aguilar R, Kim DH, Woods SC, Seeley RJ (2012) Expression of new loci associated with obesity in diet-induced obese rats: from genetics to physiology. Obesity (Silver Spring). 20:306\u2013312. https:\/\/doi.org\/10.1038\/oby.2011.236","journal-title":"Obesity (Silver Spring)."},{"key":"2476_CR66","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.3748\/wjg.v23.i41.7347","volume":"23","author":"IA Malik","year":"2017","unstructured":"Malik IA, Wilting J, Ramadori G, Naz N (2017) Reabsorption of iron into acutely damaged rat liver: a role for ferritins. World J Gastroenterol. 23:7347\u20137358. https:\/\/doi.org\/10.3748\/wjg.v23.i41.7347","journal-title":"World J Gastroenterol."},{"key":"2476_CR67","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1039\/c3mt00347g","volume":"6","author":"DB Kell","year":"2014","unstructured":"Kell DB, Pretorius E (2014) Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 6:748\u2013773. https:\/\/doi.org\/10.1039\/c3mt00347g","journal-title":"Metallomics."},{"key":"2476_CR68","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.3748\/wjg.v20.i15.4382","volume":"20","author":"S Zelber-Sagi","year":"2014","unstructured":"Zelber-Sagi S, Buch A, Yeshua H, Vaisman N, Webb M, Harari G, Kis O, Fliss-Isakov N, Izkhakov E, Halpern Z et al (2014) Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J Gastroenterol. 20:4382\u20134392. https:\/\/doi.org\/10.3748\/wjg.v20.i15.4382","journal-title":"World J Gastroenterol."},{"key":"2476_CR69","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/apt.15427","volume":"50","author":"Y Huber","year":"2019","unstructured":"Huber Y, Pfirrmann D, Gebhardt I, Labenz C, Gehrke N, Straub BK, Ruckes C, Bantel H, Belda E, Cl\u00e9ment K et al (2019) Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program. Aliment Pharmacol Ther. 50:930\u2013939. https:\/\/doi.org\/10.1111\/apt.15427","journal-title":"Aliment Pharmacol Ther."},{"key":"2476_CR70","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/jhg.2017.74","volume":"62","author":"T Umemura","year":"2017","unstructured":"Umemura T, Joshita S, Hamano H, Yoshizawa K, Kawa S, Tanaka E, Ota M (2017) Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients. J Hum Genet. 62:963\u2013967. https:\/\/doi.org\/10.1038\/jhg.2017.74","journal-title":"J Hum Genet."},{"key":"2476_CR71","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/ijms18040787","volume":"18","author":"Y Heianza","year":"2017","unstructured":"Heianza Y, Qi L (2017) Gene-diet interaction and precision nutrition in obesity. Int J Mol Sci. 18:787. https:\/\/doi.org\/10.3390\/ijms18040787","journal-title":"Int J Mol Sci."},{"key":"2476_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000486962","volume":"11","author":"J Giuranna","year":"2018","unstructured":"Giuranna J, Volckmar AL, Heinen A, Peters T, Schmidt B, Spieker A, Straub H, Grallert H, M\u00fcller TD, Antel J et al (2018) The effect of SH2B1 variants on expression of leptin- and insulin-induced pathways in murine hypothalamus. Obes Facts. 11:93\u2013108. https:\/\/doi.org\/10.1159\/000486962","journal-title":"Obes Facts."},{"key":"2476_CR73","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.2105\/AJPH.2016.303326","volume":"106","author":"A Hruby","year":"2016","unstructured":"Hruby A, Manson JE, Qi L, Malik VS, Rimm EB, Sun Q, Willett WC, Hu FB (2016) Determinants and consequences of obesity. Am J Public Health. 106:1656\u20131662. https:\/\/doi.org\/10.2105\/AJPH.2016.303326","journal-title":"Am J Public Health."},{"key":"2476_CR74","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41467-020-15328-3","volume":"11","author":"L Jiang","year":"2020","unstructured":"Jiang L, Su H, Wu X, Shen H, Kim MH, Li Y, Myers MG Jr, Owyang C, Rui L (2020) Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease. Nat Commun. 11:1517. https:\/\/doi.org\/10.1038\/s41467-020-15328-3","journal-title":"Nat Commun."},{"key":"2476_CR75","doi-asserted-by":"publisher","first-page":"43684","DOI":"10.1074\/jbc.M408495200","volume":"279","author":"C Duan","year":"2004","unstructured":"Duan C, Li M, Rui L (2004) SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. J Biol Chem. 279:43684\u201343691. https:\/\/doi.org\/10.1074\/jbc.M408495200","journal-title":"J Biol Chem."},{"key":"2476_CR76","doi-asserted-by":"publisher","first-page":"E1064","DOI":"10.3390\/nu9101064","volume":"9","author":"F Hosseini-Esfahani","year":"2017","unstructured":"Hosseini-Esfahani F, Koochakpoor G, Daneshpour MS, Sedaghati-Khayat B, Mirmiran P, Azizi F (2017) Mediterranean dietary pattern adherence modify the association between FTO genetic variations and obesity phenotypes. Nutrients 9:E1064. https:\/\/doi.org\/10.3390\/nu9101064","journal-title":"Nutrients"},{"key":"2476_CR77","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.3390\/nu11112600","volume":"11","author":"V Serafim","year":"2019","unstructured":"Serafim V, Chirita-Emandi A, Andreescu N, Tiugan DA, Tutac P, Paul C, Velea I, Mihailescu A, \u0218erban CL, Zimbru CG et al (2019) Single nucleotide polymorphisms in PEMT and MTHFR genes are associated with omega 3 and 6 fatty acid levels in the red blood cells of children with obesity. Nutrients. 11:2600. https:\/\/doi.org\/10.3390\/nu11112600","journal-title":"Nutrients."},{"key":"2476_CR78","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820958298","author":"V Bull\u00f3n-Vela","year":"2020","unstructured":"Bull\u00f3n-Vela V, Abete I, Tur JA, Konieczna J, Romaguera D, Pint\u00f3 X, Corbella E, Mart\u00ednez-Gonz\u00e1lez MA, Say\u00f3n-Orea C, Toledo E et al (2020) Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications. Ther Adv Endocrinol Metab. https:\/\/doi.org\/10.1177\/2042018820958298","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-020-02476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-020-02476-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-020-02476-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T08:04:12Z","timestamp":1628582652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-020-02476-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2476"],"URL":"https:\/\/doi.org\/10.1007\/s00394-020-02476-x","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest concerning this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the Research Ethics Committee of the University of Navarra on 24 April 2015 (ref. 54\/2015) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its latter amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"All participants gave written informed consent in a clinical interview for their participation in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}